Literature DB >> 9488928

[Evaluation of insomnia: validity of 3 questionnaires].

F C Blais1, L Gendron, V Mimeault, C M Morin.   

Abstract

Insomnia is a widespread problem impairing daytime functioning and carrying important social and economic costs. No valid instrument exists in French to assess sleep difficulties. Two studies assess the French translation of three insomnia measures. The Pittsburgh Sleep Quality Index (PSQI), the Sleep Impairment Rating Scales (SIRS) and the Beliefs and Attitudes about Sleep (BAS) questionnaires were selected according to their clinical utility. Study one established the inferential translation of the preliminary versions with six expert judges. The empirical equivalence of the original and translated versions were confirmed with bilingual nonclinical sample. Study two assessed the fidelity and convergent validity of these instruments with a nonclinical French sample. The results showed adequate internal consistency; test-retest fidelity for a two-week interval was acceptable. The findings on convergent validity are also appropriate. While future research is necessary to confirm their psychometric properties, these questionnaires are good measures to assess insomnia in a research or clinical context.

Entities:  

Mesh:

Year:  1997        PMID: 9488928

Source DB:  PubMed          Journal:  Encephale        ISSN: 0013-7006            Impact factor:   1.291


  45 in total

1.  "I'd eat a bucket of nails if you told me it would help me sleep:" perceptions of insomnia and its treatment in patients with stable heart failure.

Authors:  Laura Kierol Andrews; Jessica Coviello; Elisabeth Hurley; Leonie Rose; Nancy S Redeker
Journal:  Heart Lung       Date:  2013 Sep-Oct       Impact factor: 2.210

Review 2.  A systematic review of patient-reported outcome instruments measuring sleep dysfunction in adults.

Authors:  Emily Beth Devine; Zafar Hakim; Jesse Green
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

3.  Cognitive Behavioral Insomnia Therapy for Those With Insomnia and Depression: A Randomized Controlled Clinical Trial.

Authors:  Colleen E Carney; Jack D Edinger; Maragatha Kuchibhatla; Angela M Lachowski; Olya Bogouslavsky; Andrew D Krystal; Colin M Shapiro
Journal:  Sleep       Date:  2017-04-01       Impact factor: 5.849

4.  The role of the spontaneous and evoked k-complex in good-sleeper controls and in individuals with insomnia.

Authors:  Daniel Forget; Charles M Morin; Clyne H Bastien
Journal:  Sleep       Date:  2011-09-01       Impact factor: 5.849

5.  Screening for clinical insomnia in cancer patients with the Edmonton Symptom Assessment System-Revised: a specific sleep item is needed.

Authors:  Josée Savard; Hans Ivers
Journal:  Support Care Cancer       Date:  2019-02-04       Impact factor: 3.603

Review 6.  Insomnia in children: when are hypnotics indicated?

Authors:  Mohammed Younus; Michael J Labellarte
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

7.  Hormones and cognitive functioning during late pregnancy and postpartum: a longitudinal study.

Authors:  Jessica F Henry; Barbara B Sherwin
Journal:  Behav Neurosci       Date:  2011-09-19       Impact factor: 1.912

8.  Effects of Cognitive Behavioral Therapy for Insomnia on Sleep, Symptoms, Stress, and Autonomic Function Among Patients With Heart Failure.

Authors:  Nancy S Redeker; Samantha Conley; George Anderson; John Cline; Laura Andrews; Vahid Mohsenin; Daniel Jacoby; Sangchoon Jeon
Journal:  Behav Sleep Med       Date:  2018-11-21       Impact factor: 2.964

9.  Examining maladaptive beliefs about sleep across insomnia patient groups.

Authors:  Colleen E Carney; Jack D Edinger; Charles M Morin; Rachel Manber; Bruce Rybarczyk; Edward J Stepanski; Helen Wright; Leon Lack
Journal:  J Psychosom Res       Date:  2010-01       Impact factor: 3.006

10.  Capacity of the Edmonton Symptom Assessment System and the Canadian Problem Checklist to screen clinical insomnia in cancer patients.

Authors:  Josée Savard; Hans Ivers; Marie-Hélène Savard
Journal:  Support Care Cancer       Date:  2016-05-18       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.